TRDA Entrada Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$5,38
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,1752-Wochen-Tief
$16,4552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$209M
P/E (TTM)
-1.4
EPS (TTM)
$-3.97
Umsatz (TTM)
$5M
Ihre Abzeichen
52W-Spanne
$5–$16
Analystenbewertung
BUY
Kursziel
$19
P/E
-1.4
ROE
-54.1%
Nettogewinnmarge
-3537.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
TRDA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.38
Marktkapitalisierung (MRQ)
$209M
P/E (TTM)
-1.4
EPS (TTM)
$-3.97
Umsatz (TTM)
$5M
ROE (TTM)
-54.1%
52W-Spanne
$5–$16
TRDA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$25M2023-12-31 → 2025-12-31
EPS$-3.472020-12-31 → 2025-12-31
Freier Cashflow$-130M2021-12-31 → 2025-12-31
Nettogewinnmarge-3537.7%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | TRDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.45-Jahres-Durchschnitt ≈-14.9 | ≈-14.9 | · | · | |
| P/S (TTM) | 44.75-Jahres-Durchschnitt ≈7.5 | ≈7.5 | 16.1 | Überbewertet | |
| K/B (MRQ) | 0.95-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 1.3 | Fairer Wert | |
| Kurs / FCF (TTM) | -1.65-Jahres-Durchschnitt ≈-5.9 | ≈-5.9 | · | · | |
| Kurs / Cashflow (TTM) | -1.65-Jahres-Durchschnitt ≈-6.4 | ≈-6.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.75-Jahres-Durchschnitt ≈1.7 | ≈1.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | TRDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -3767.1%5-Jahres-Durchschnitt ≈-200.4% | ≈-200.4% | -1601.1% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -621.1%5-Jahres-Durchschnitt ≈-200.4% | ≈-200.4% | -1600.0% | Schwach | |
| Nettogewinnmarge (TTM) | -3537.7%5-Jahres-Durchschnitt ≈-179.8% | ≈-179.8% | -1943.2% | Schwach | |
| ROA (TTM) | -44.3%5-Jahres-Durchschnitt ≈-12.4% | ≈-12.4% | -27.9% | Schwach | |
| ROE (TTM) | -54.1%5-Jahres-Durchschnitt ≈-18.6% | ≈-18.6% | -27.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | TRDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 10.95-Jahres-Durchschnitt ≈17.6 | ≈17.6 | 9.4 | Im Einklang | |
| Quick Ratio | 3.75-Jahres-Durchschnitt ≈12.5 | ≈12.5 | 7.4 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | TRDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -87.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | TRDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.1 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$167.2K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.8%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-1.01 | $-1.07 | 5.7% |
| 31. März 2026 | $-0.95 | $-1.06 | 10.2% | |
| 31. Dezember 2025 | $-0.94 | $-1.17 | 19.9% | |
| 30. September 2025 | $-1.06 | $-0.96 | -10.6% | |
| 30. Juni 2025 | $-1.04 | $-0.86 | -20.3% | |
| 31. März 2025 | $-0.42 | $-0.80 | 47.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $211M | $129M | |
| R&D Expense | $142M | $125M | $100M | |
| SG&A Expense | $41M | $38M | $32M | |
| Operating Expenses | $183M | $164M | $132M | |
| Operating Income | $-158M | $47M | $-3M | |
| Other Non-op | $15M | $19M | $15M | |
| Income Tax | $924.0K | $859.0K | $19M | |
| Net Income | $-144M | $66M | $-7M | |
| EPS (Basic) | $-3.47 | $1.76 | $-0.20 | |
| EPS (Diluted) | $-3.47 | $1.68 | $-0.20 | |
| Shares (Basic) | 41,371,486 | 37,306,363 | 33,050,319 | |
| Shares (Diluted) | 41,371,486 | 39,003,169 | 33,050,319 | |
| EBITDA | $-158M | $47M | $-3M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $90M | $101M | $68M | |
| Prepaid Expense | $9M | $16M | $12M | |
| Current Assets | $306M | $440M | $370M | |
| PP&E (Net) | $7M | $11M | $11M | |
| PP&E (Gross) | $17M | $20M | $17M | |
| Accum. Depreciation | $10M | $9M | $6M | |
| Other Non-current Assets | $70.0K | $284.0K | $3M | |
| Total Assets | $377M | $526M | $469M | |
| Accounts Payable | $2M | $4M | $3M | |
| Accrued Liabilities | $18M | $13M | $11M | |
| Current Liabilities | $24M | $39M | $159M | |
| Capital Leases | $47M | $52M | $60M | |
| Total Liabilities | $71M | $98M | $227M | |
| Common Stock | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $579M | $558M | $437M | |
| Retained Earnings | $-273M | $-129M | $-195M | |
| AOCI | $652.0K | $-43.0K | $195.0K | |
| Stockholders' Equity | $306M | $429M | $242M | |
| Liabilities + Equity | $377M | $526M | $469M | |
| Shares Outstanding | 38,284,221 | 37,574,538 | 33,437,296 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $20M | $18M | $13M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-129M | $-42M | $140M | |
| CapEx | $1M | $3M | $6M | |
| Investing Cash Flow | $117M | $-28M | $-138M | |
| Financing Cash Flow | $887.0K | $103M | $21M | |
| Net Change in Cash | $-11M | $34M | $22M | |
| Taxes Paid | $2M | $5M | $15M | |
| Free Cash Flow | $-130M | $-45M | $134M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -621.1% | 22.3% | -2.5% | |
| Net Margin | -565.5% | 31.1% | -5.2% | |
| EBITDA Margin | -621.1% | 22.3% | -2.5% | |
| ROA | -31.8% | 13.2% | -1.8% | |
| ROE | -41.9% | 15.4% | -2.7% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.5 | 11.1 | 2.3 | |
| Quick Ratio | 3.7 | 2.6 | 0.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.4 | 0.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $8.00 | $11.41 | $7.25 | |
| Revenue / Share | $0.61 | $5.40 | $3.90 | |
| Cash Flow / Share | $-3.11 | $-1.07 | $4.23 | |
| Cash / Share | $2.36 | $2.69 | $2.02 | |
| EPS (TTM) | $-3.47 | $1.68 | $-0.20 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -87.9% | 63.4% | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $211M | $129M | |
| Net Income TTM | $-144M | $66M | $-7M | |
| Market Cap | $394M | $650M | $505M | |
| P/E | -3.0 | 10.3 | -75.5 | |
| P/S | 15.5 | 3.1 | 3.9 | |
| P/B | 1.3 | 1.5 | 2.1 | |
| P / Tangible Book | 1.3 | 1.5 | 2.1 | |
| P / Cash Flow | -3.1 | -15.6 | 3.6 | |
| P / FCF | -3.0 | -14.5 | 3.8 | |
| Earnings Yield | -33.8% | 9.7% | -1.3% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $898.0K | $875.0K | $1M | $2M | $2M | $21M | $37M | $20M | $95M | $59M | $42M | $44M | $18M | $25M | · | $0 | |
| R&D Expense | $35M | $33M | $34M | $38M | $38M | $32M | $33M | $31M | $32M | $29M | $28M | $22M | $26M | $23M | $16M | $19M | |
| SG&A Expense | $10M | $10M | $10M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $7M | |
| Operating Expenses | $46M | $43M | $44M | $49M | $49M | $42M | $43M | $41M | $41M | $38M | $37M | $30M | $34M | $31M | $26M | $26M | |
| Operating Income | $-45M | $-42M | $-42M | $-47M | $-47M | $-22M | $-6M | $-22M | $53M | $21M | $5M | $14M | $-16M | $-6M | $-26M | $-26M | |
| Other Non-op | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $950.0K | $799.0K | |
| Income Tax | $35.0K | $38.0K | $92.0K | $654.0K | $178.0K | $0 | $-2M | $-2M | $3M | $2M | $19M | $-17M | $14M | $4M | $0 | $0 | |
| Net Income | $-43M | $-40M | $-39M | $-44M | $-43M | $-17M | $1M | $-14M | $55M | $23M | $-10M | $35M | $-26M | $-7M | $-25M | $-25M | |
| EPS (Basic) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.61 | $0.70 | $-0.28 | $1.07 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| EPS (Diluted) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.55 | $0.68 | $-0.23 | $1.02 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| Shares (Basic) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 34,180,549 | 33,497,072 | · | 33,281,287 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| Shares (Diluted) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 35,507,029 | 34,790,925 | · | 34,775,451 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| EBITDA | $-45M | $-42M | · | $-47M | $-47M | $-22M | · | $-22M | $53M | $21M | · | $14M | $-16M | · | · | $-26M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $76M | $90M | $93M | $72M | $68M | $101M | $78M | $185M | $68M | $68M | $52M | $80M | $228M | $45M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $162M | |
| Prepaid Expense | $9M | $11M | $9M | $10M | $14M | $19M | $16M | $13M | $12M | $9M | $12M | $24M | $10M | $16M | $21M | $19M | |
| Current Assets | $233M | $267M | $306M | $338M | $369M | $403M | $440M | $465M | $490M | $414M | $370M | $383M | $390M | $434M | $210M | $235M | |
| PP&E (Net) | $6M | $7M | $7M | $8M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $8M | $7M | |
| PP&E (Gross) | $16M | $17M | $17M | $19M | $21M | $21M | $20M | $19M | $19M | $18M | $17M | $16M | $15M | $13M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Other Non-current Assets | $118.0K | $90.0K | $70.0K | $163.0K | $199.0K | $239.0K | $284.0K | $746.0K | $747.0K | $3M | $3M | $3M | $538.0K | $14M | $5M | $954.0K | |
| Total Assets | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $2M | $2M | $4M | $1M | $2M | $3M | $3M | $752.0K | $2M | $6M | $6M | $1M | |
| Accrued Liabilities | $13M | $12M | $18M | $16M | $12M | $8M | $13M | $13M | $11M | $9M | $11M | $10M | $7M | $12M | $8M | $12M | |
| Current Liabilities | $21M | $19M | $24M | $24M | $20M | $18M | $39M | $71M | $86M | $174M | $159M | $165M | $126M | $148M | $22M | $22M | |
| Capital Leases | $44M | $45M | $47M | $48M | $49M | $50M | $52M | $54M | $56M | $58M | $60M | $62M | $66M | $9M | $18M | $20M | |
| Total Liabilities | $65M | $65M | $71M | $72M | $69M | $69M | $98M | $132M | $152M | $241M | $227M | $238M | $287M | $246M | $40M | $41M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $589M | $583M | $579M | $574M | $569M | $564M | $558M | $552M | $547M | $441M | $437M | $433M | $429M | $425M | $403M | $400M | |
| Retained Earnings | $-356M | $-313M | $-273M | $-234M | $-190M | $-147M | $-129M | $-130M | $-116M | $-171M | $-195M | $-185M | $-221M | $-195M | $-188M | $-164M | |
| AOCI | $66.0K | $246.0K | $652.0K | $621.0K | $400.0K | $437.0K | $-43.0K | $972.0K | $-329.0K | $-246.0K | $195.0K | $-496.0K | $-1M | $-642.0K | $-2M | $-3M | |
| Stockholders' Equity | $233M | $271M | $306M | $341M | $380M | $417M | $429M | $422M | $430M | $269M | $242M | $247M | $207M | $230M | $213M | $233M | |
| Liabilities + Equity | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Shares Outstanding | 38,936,669 | 38,820,616 | 38,284,221 | 38,219,232 | 38,033,970 | 37,942,283 | 37,574,538 | 37,400,499 | 37,172,496 | 33,604,053 | 33,437,296 | 33,340,216 | 33,205,693 | 33,133,736 | 31,394,767 | 31,325,373 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-42M | $-32M | $-28M | $-29M | $-39M | $-32M | $-24M | $40M | $-26M | $-4M | $-24M | $-35M | $203M | $-27M | $-27M | |
| CapEx | $11.0K | $44.0K | $-207.0K | $-171.0K | $275.0K | $1M | $635.0K | $639.0K | $1M | $838.0K | $976.0K | $1M | $2M | $2M | $708.0K | $810.0K | |
| Investing Cash Flow | $55M | $27M | $29M | $49M | $34M | $5M | $53M | $-83M | $-24M | $26M | $19M | $-4M | $-113M | $-40M | $19M | $-10M | |
| Stock Issued | · | · | · | $0 | · | · | · | $-392.0K | $100M | $0 | · | $0 | $0 | $19M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $350.0K | $100.0K | $192.0K | $8.0K | $337.0K | $350.0K | $1M | $-11.0K | $101M | $206.0K | $690.0K | $368.0K | $443.0K | $20M | $358.0K | $60.0K | |
| Net Change in Cash | $23M | $-15M | $-3M | $21M | $5M | $-33M | $23M | $-107M | $117M | $834.0K | $16M | $-28M | $-148M | $182M | $-8M | $-38M | |
| Free Cash Flow | · | $-42M | · | · | · | $-40M | · | · | · | $-26M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| Net Margin | -4762.0% | -4539.1% | · | -2734.4% | -2210.4% | -84.4% | · | -71.7% | 58.1% | 39.7% | · | 81.1% | -142.7% | · | · | · | |
| EBITDA Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| ROA | -11.4% | -9.7% | · | -9.1% | -8.4% | -3.5% | · | -2.7% | 10.2% | 4.8% | · | 9.3% | -6.6% | · | · | -12.4% | |
| ROE | -14.0% | -11.5% | · | -11.6% | -10.7% | -5.1% | · | -4.2% | 17.3% | 9.4% | · | 14.8% | -11.2% | · | · | -31.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.9 | · | 14.1 | 18.6 | 21.9 | · | 6.6 | 5.7 | 2.4 | · | 2.3 | 3.1 | · | · | 10.9 | |
| Quick Ratio | 4.6 | 4.0 | · | 3.9 | 3.7 | 3.7 | · | 1.1 | 2.2 | 0.4 | · | 0.3 | 0.6 | · | · | 10.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.0 | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.99 | $6.98 | · | $8.91 | $9.98 | $11.00 | · | $11.30 | $11.57 | $8.02 | · | $7.40 | $6.23 | · | · | $7.45 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.04 | $0.05 | $0.50 | · | $0.48 | $2.67 | $1.70 | · | $1.26 | $0.55 | · | · | · | |
| Cash Flow / Share | · | $-1.00 | · | · | · | $-0.94 | · | · | · | $-0.73 | · | · | · | · | · | · | |
| Cash / Share | $2.55 | $1.97 | · | $2.44 | $1.91 | $1.79 | · | $2.09 | $4.98 | $2.04 | · | $1.56 | $2.40 | · | · | $1.70 | |
| EPS (TTM) | $-3.97 | $-4.00 | · | $-2.72 | $-2.01 | $0.58 | · | $1.65 | $3.02 | $0.69 | · | $-0.76 | $-2.58 | $-2.44 | · | $13.62 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $6M | · | $62M | $79M | $172M | · | $215M | $239M | $163M | · | · | · | $25M | · | · | |
| Net Income TTM | $-166M | $-166M | · | $-103M | $-73M | $25M | · | $55M | $104M | $23M | · | $-22M | $-82M | $-77M | · | $-88M | |
| Market Cap | $287M | $490M | · | $222M | $256M | $343M | · | $598M | $530M | $476M | · | $527M | $503M | · | · | $494M | |
| P/E | -1.9 | -3.2 | · | -2.1 | -3.3 | 15.6 | · | 9.7 | 4.7 | 20.5 | · | -20.8 | -5.9 | -5.9 | · | 1.2 | |
| P/S | 61.2 | 85.4 | · | 3.6 | 3.2 | 2.0 | · | 2.8 | 2.2 | 2.9 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | · | · | 2.1 | |
| P / Tangible Book | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | 2.1 | · | 2.1 | |
| P / Cash Flow | · | -11.8 | · | · | · | -8.9 | · | · | · | -18.7 | · | · | · | · | · | · | |
| Earnings Yield | -53.9% | -31.7% | · | -46.9% | -29.9% | 6.4% | · | 10.3% | 21.2% | 4.9% | · | -4.8% | -17.0% | -16.8% | · | 86.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $25M | $211M | $129M | · | · |
| Betriebsgewinnmarge % | -621.1% | 22.3% | -2.5% | · | · |
| Nettoergebnis | $-144M | $66M | $-7M | $-95M | $-51M |
| Verwässerte EPS | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.5 | 11.1 | 2.3 | · | 44.5 |
| Quick Ratio | 3.7 | 2.6 | 0.4 | · | 43.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-130M | $-45M | $134M | · | $-55M |
Institutionelle Eigentümer (13F) 135 Einreicher · $254.0M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
135
Gehaltener Wert
$254.0M
Neue Positionen
28
Geschlossene Positionen
16
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 28 (+6 vs. Vorquartal) | 16 (+4 vs. Vorquartal) | 53 (+6 vs. Vorquartal) | 31 (+1 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $37.335.293 | 5.072.730 | 14,70% | Aktien |
| 5AM Venture Management, LLC | $29.854.949 | 4.056.379 | 11,76% | Aktien |
| MPM ASSET MANAGEMENT LLC | $25.410.160 | 4.381.062 | 10,01% | Aktien |
| BlackRock, Inc. | $19.013.332 | 2.583.333 | 7,49% | Aktien |
| VANGUARD GROUP INC | $16.781.689 | 1.632.460 | 6,61% | Aktien |
| Merck & Co., Inc. | $12.804.692 | 1.739.768 | 5,04% | Aktien |
| StepStone Group LP | $9.607.316 | 761.277 | 3,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.344.506 | 1.269.634 | 3,68% | Aktien |
| MPM BIOIMPACT LLC | $9.222.470 | 1.253.053 | 3,63% | Aktien |
| TCG Crossover Management, LLC | $7.803.293 | 1.060.230 | 3,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $7.024.524 | 954.419 | 2,77% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.622.738 | 763.959 | 2,21% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.281.368 | 717.430 | 2,08% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $5.148.591 | 699.537 | 2,03% | Aktien |
| STATE STREET CORP | $4.391.543 | 596.677 | 1,73% | Aktien |
| JPMORGAN CHASE & CO | $3.827.683 | 496.457 | 1,51% | Aktien |
| CITADEL ADVISORS LLC | $2.902.217 | 394.323 | 1,14% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $2.769.577 | 376.136 | 1,09% | Aktien |
| NORTHERN TRUST CORP | $2.281.173 | 309.942 | 0,90% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.233.458 | 303.459 | 0,88% | Aktien |
| Nantahala Capital Management, LLC | $2.212.232 | 300.575 | 0,87% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.870.397 | 254.130 | 0,74% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.450.921 | 197.136 | 0,57% | Aktien |
| Longaeva Partners L.P. | $1.436.944 | 195.237 | 0,57% | Aktien |
| MORGAN STANLEY | $1.410.544 | 191.650 | 0,56% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.405.760 | 191.000 | 0,55% | Aktien |
| Quantinno Capital Management LP | $1.389.855 | 188.839 | 0,55% | Aktien |
| Lynx1 Capital Management LP | $1.314.540 | 178.606 | 0,52% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.305.247 | 177.343 | 0,51% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.233.875 | 167.646 | 0,49% | Aktien |
| Woodline Partners LP | $1.071.616 | 145.600 | 0,42% | Aktien |
| Trexquant Investment LP | $1.031.452 | 140.143 | 0,41% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $772.800 | 105.000 | 0,30% | Aktien |
| Cubist Systematic Strategies, LLC | $711.521 | 122.676 | 0,28% | Aktien |
| XTX Topco Ltd | $701.680 | 95.337 | 0,28% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $699.524 | 95.044 | 0,28% | Aktien |
| Allspring Global Investments Holdings, LLC | $688.440 | 93.538 | 0,27% | Aktien |
| ROYCE & ASSOCIATES LP | $610.159 | 82.902 | 0,24% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $586.599 | 79.701 | 0,23% | Aktien |
| Bank of New York Mellon Corp | $581.955 | 79.070 | 0,23% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $533.747 | 72.520 | 0,21% | Aktien |
| AMERIPRISE FINANCIAL INC | $518.107 | 70.395 | 0,20% | Aktien |
| Qube Research & Technologies Ltd | $448.018 | 60.872 | 0,18% | Aktien |
| CANTOR FITZGERALD, L. P. | $441.600 | 60.000 | 0,17% | Aktien |
| BANK OF AMERICA CORP /DE/ | $426.343 | 57.927 | 0,17% | Aktien |
| Nuveen, LLC | $417.879 | 56.777 | 0,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $399.297 | 31.640 | 0,16% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $398.272 | 54.113 | 0,16% | Aktien |
| TD Asset Management Inc | $394.408 | 53.588 | 0,16% | Aktien |
| ExodusPoint Capital Management, LP | $388.365 | 52.767 | 0,15% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ANSBERT GADICKE, LUKE EVNIN, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BIOVENTURES 2018, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Todd Foley | 10. September 2026 | 9,90% | Änderung | · | SEC |
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage | 18. November 2025 | 10,80% | Änderung | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×2 Einreichungen | 26. Juni 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2018, L.P., MPM BioVentures 2018 (B), L.P., MPM Asset Management Investors BV2018 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Ansbert Gadicke, Luke Evnin, Todd Foley, Edward Hurwitz | 12. November 2021 | · | Erste Einreichung | Passive Anlage | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage | 12. November 2021 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 14 Insider · 5 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dipal Doshi | CEO | 2. September 2026 F | 517.290 | 0 | 0 | $0 |
| Kory James Wentworth | Chief Financial Officer | 2. September 2026 F | 117.277 | 0 | 5 | $-433.579 |
| Natarajan Sethuraman | President, Research & Develop. | 2. September 2026 F | 214.238 | 0 | 1 | $-398.709 |
| Nathan J Dowden | President & COO | 2. September 2026 F | 196.060 | 0 | 3 | $-425.737 |
| Nerissa Kreher | Chief Medical Officer | 1. September 2023 A | 40.037 | 0 | 0 | $0 |
| Kush Parmar | Direktor | 10. August 2026 S | 2.691.337 | 0 | 6 | $-3.645.964 |
| Maha Radhakrishnan | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Gina Chapman | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Bernhardt G Zeiher | Direktor | 10. Juni 2026 A | 5.000 | 1 | 0 | $29.300 |
| Mary Thistle | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Peter S Kim | Direktor | 10. Juni 2026 A | 117.412 | 0 | 0 | $0 |
| John F Crowley | Direktor | 8. Juni 2023 A | 5.000 | 0 | 0 | $0 |
| Carole Nuechterlein | Direktor | 2. Juni 2022 A | · | 0 | 0 | $0 |
| Todd Foley | Direktor | 2. Juni 2022 A | 4.425.784 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,15% | 1.770 SH | 11. September 2026 | Täglich |
| HAPS · Harbor ETF Trust | 0,13% | 33.369 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,04% | 100.286 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 2.754 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 203.253 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 169.170 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 25.636 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 34.560 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 14.068 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 753.989 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 108.498 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.856 NS | 31. Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 12.272 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.020 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.231 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.896 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7.674 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 283.038 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 953.727 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.999 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 2.069 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 57.325 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 269.374 SH | 11. September 2026 | Täglich |
TRDA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$20.00
+271,7%
5 35,7%
Starker Kauf
7 50,0%
Kauf
2 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-03Mittelwert-Ziel $19.00 +253,2%
← Unter allen Zielen
Aktueller Preis $5.38
Tief$11.00
Mittelwert$19.00
Hoch$25.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026